Updated Cervical Cancer Screening Guidelines

In January 2026, the Women’s Preventive Services Initiative (WPSI), a multidisciplinary expert panel supported by the Health Resources and Services Administration, issued updated cervical cancer screening guidelines. These guidelines apply to women at average risk for cervical cancer; they do not apply to patients with HIV infection, immunosuppression, in utero diethylstilbestrol exposure, or a history of grade 2 or higher cervical dysplasia, which require individualized management. This update from the 2021 guidelines draws primarily on the evidence review commissioned for the 2024 U.S. Preventive Services Task For…